Context Therapeutics stock price
콘텍스트 테라퓨틱스NASDAQ:CNTX · Nasdaq · Healthcare$0.3097-1.49%
2026-10-02 closeLoading chart…
Today's signals · RSI rebound
Signal details →Context Therapeutics last closed at $0.3097 (-1.49%) on 2026-10-02. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is -0.6×. Its overall grade ranks 689 of 739 stocks in Healthcare.
About this company
Context Therapeutics last closed at $0.3097 (-1.49%) on 2026-10-02. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 689/739
Valuation grade C+
Related stocks
- Gilead SciencesCompetitor
항암·면역 분야 대형 바이오로 T세포/이중항체 계열 경쟁 구도
- AmgenCompetitor
종양학 바이오신약 개발사로 면역항암 파이프라인 경쟁
- GenmabCompetitor
이중항체·항암항체 강자로 유사 기전의 경쟁사
About Context Therapeutics
- What technical signals does Context Therapeutics (CNTX) have?
- Context Therapeutics current technical signals: RSI rebound.
- Is Context Therapeutics a cup-and-handle pattern?
- No. Context Therapeutics has no valid Cup signal right now.
- What published figures are available for Context Therapeutics?
- Market cap: $28.45M. Trailing 12 months PER: -0.6×. Latest quarter PBR: 0.77×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Context Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy